Menu
Finnish Flagships: the courage to reform research
iCAN is part of the Academy of Finland’s Flagship Programme. The ten Flagships create high-quality research, sustainable solutions, and societal impact.
Uusi keuhkosyövän biomarkkeri voi auttaa ennustamaan immuuniterapioiden sopivuutta potilaille
iCANin tutkijoiden tunnistama uusi biomarkkeri ennakoi syöpäkasvaimen kykyä estää kehon immuunijärjestelmän toimintaa.
iCAN researchers identify new biomarker with potential to predict immunotherapy response in lung cancer
The newly discovered biomarker may help to distinguish which patients are more likely to benefit from immunotherapies.
- Go to the previous page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- Go to the next page